QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: jpet.107.133413v1 326/1/89    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sheets, P. L. Articles by Cummins, T. R. Search for Related Content PubMed PubMed Citation Articles by Sheets, P. L. Articles by Cummins, T. R.

NEUROPHARMACOLOGY

Differential Block of Sensory Neuronal Voltage-Gated Sodium Channels by Lacosamide [(2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide], Lidocaine, and Carbamazepine

Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana (P.L.S., T.R.C.); and Department of Pharmacology/Toxicology, Schwarz BioSciences, GmbH, Monheim, Germany (C.H., T.S.)

Voltage-gated sodium channels play a critical role in excitability of nociceptors (pain-sensing neurons). Several different sodium channels are thought to be potential targets for pain therapeutics, including Na_v1.7, which is highly expressed in nociceptors and plays crucial roles in human pain and hereditary painful neuropathies, Na_v1.3, which is up-regulated in sensory neurons following chronic inflammation and nerve injury, and Na_v1.8, which has been implicated in inflammatory and neuropathic pain mechanisms. We compared the effects of lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], a new pain therapeutic, with those of lidocaine and carbamazepine on recombinant Na_v1.7 and Na_v1.3 currents and neuronal tetrodotoxin-resistant (Na_v1.8-type) sodium currents using whole-cell patch-clamp electrophysiology. Lacosamide is able to substantially reduce all three current types. However, in contrast to lidocaine and carbamazepine, 1 mM lacosamide did not alter steady-state fast inactivation. Inhibition by lacosamide exhibited substantially slower kinetics, consistent with the proposal that lacosamide interacts with slow-inactivated sodium channels. The estimated IC₅₀ values for inhibition by lacosamide of Na_v1.7-, Na_v1.3-, and Na_v1.8-type channels following prolonged inactivation were 182, 415, and 16 µM, respectively. Na_v1.7-, Na_v1.3-, and Na_v1.8-type channels in the resting state were 221-, 123-, and 257-fold less sensitive, respectively, to lacosamide than inactivated channels. Interestingly, the ratios of resting to inactivated IC₅₀s for carbamazepine and lidocaine were much smaller (ranging from 3 to 16). This suggests that lacosamide should be more effective than carbamazepine and lidocaine at selectively blocking the electrical activity of neurons that are chronically depolarized compared with those at more normal resting potentials.

Address correspondence to: Dr. Theodore Cummins, Department of Pharmacology and Toxicology, Indiana University School of Medicine, 950 West Walnut St., R2 468, Indianapolis, IN. E-mail: trcummin{at}iupui.edu